SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Company: Dopamine Transporter Modulators for Parkinson's Disease

company 617 words KG: dopamine 2026-03-25

section:companies kind:company state:published

Contents

Dopamine Transporter Modulators for Parkinson's Disease

Knowledge Graph

Related Hypotheses (30)

Mitochondrial SPM Synthesis Platform Engineering
Score: 0.38 SASP-Mediated Complement Cascade Amplification
Score: 0.70 Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Transcriptional Autophagy-Lysosome Coupling
Score: 0.66

CYP46A1 Overexpression Gene Therapy
Score: 0.63 Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62 Digital Twin-Guided Metabolic Reprogramming
Score: 0.61 Multi-Modal Stress Response Harmonization
Score: 0.60 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59 Circadian-Synchronized Proteostasis Enhancement
Score: 0.58 Microbial Inflammasome Priming Prevention
Score: 0.58 PARP1 Inhibition Therapy
Score: 0.58 AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.56 Smartphone-Detected Motor Variability Correction
Score: 0.56 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.56 Circadian Clock-Autophagy Synchronization
Score: 0.55 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 Senescent Cell Mitochondrial DNA Release
Score: 0.54 Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53 Vagal Afferent Microbial Signal Modulation
Score: 0.52 Membrane Cholesterol Gradient Modulators
Score: 0.52 Temporal Decoupling via Circadian Clock Reset
Score: 0.52 Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.51 Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51

Related Analyses (30)

Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived

Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.40 AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40 AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.40 Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40

Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40 Computational Modeling of Alpha-Synuclein Propagation in PD
validation · proposed · Score: 0.40 Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation
validation · proposed · Score: 0.40 Alpha-Synuclein Seed Amplification Assay Validation
clinical · proposed · Score: 0.40 Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation
exploratory · proposed · Score: 0.40 Antiviral Therapy Trial for Parkinson's Disease
clinical · proposed · Score: 0.40 Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson'
clinical · proposed · Score: 0.40 Axonal Transport Dysfunction Validation in Parkinson's Disea
clinical · proposed · Score: 0.40 cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Chaperone-Mediated Autophagy Dysfunction in PD - Experiment
clinical · proposed · Score: 0.40 Combination Therapy Sequencing in Parkinson's Disease
validation · proposed · Score: 0.40 CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40 Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa
validation · proposed · Score: 0.40 DNA Damage Repair Deficiency Validation Study in Parkinson's
clinical · proposed · Score: 0.40 Mechanism: Selective Vulnerability of Dopaminergic Neurons i
validation · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Epigenetic Dysregulation Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Exercise-BDNF-Mitophagy Biomarker Study in PD
clinical · proposed · Score: 0.40 Ferroptosis Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 GLP-1 Agonist Neuroprotection Mechanism in PD
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40 Gut-Brain Axis Pathogenesis in Parkinson's Disease — Mechani
clinical · proposed · Score: 0.40 Cytochrome Therapeutics
clinical · proposed · Score: 0.40 Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson
clinical · proposed · Score: 0.40 Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown
validation · proposed · Score: 0.40

See Also (13)

Levodopa for Parkinson's Disease — Investment Landscape
investment · KG edge: converts_to Alzheimer Indonesia
institution · KG edge: loss_affects SNCA — Alpha-Synuclein
gene · KG edge: loss_affects NRF2 Gene
gene · KG edge: activates GPX4 Gene - Glutathione Peroxidase 4
gene · KG edge: regulates

COMT Gene
gene · KG edge: regulates BDNF Gene
gene · KG edge: regulates Amyloid-Related Imaging Abnormalities (ARIA)
entity · KG edge: activates acetylcholine
general · KG edge: co_discussed Neurodegeneration
disease · KG edge: loss_affects NeuRon Therapeutics
company · KG edge: loss_affects Parkinson Basal Ganglia Circuit
circuit · KG edge: loss_affects Striatum
brain · KG edge: expressed_in

Knowledge Graph (12 edges)

dopamine regulates neuronal uptake

dopamine treats diabetic retinal neurodegeneration

dopamine activates NRF2

dopamine regulates GPX4

dopamine regulates BDNF

dopamine expressed_in striatum

dopamine expressed_in mesolimbic circuit

dopamine loss_affects neuron

dopamine loss_affects SNCA

dopamine loss_affects Alzheimer

SciDEX — scidex.ai — Dashboard | Atlas